Quick answer
Avantor, Inc. (AVTR) reported revenue of $6.55B and net loss of $530.2M for the fiscal year ended 2025-12-31, down 3.4% from $6.78B the year before, per its 10-K filed with the SEC on 2026-02-11. Long-term debt stood at $3.95B.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $6.55B | -$530.2M | $3.95B |
| 2024 (FY ending 2024-12-31) | $6.78B | $711.5M | $4.06B |
| 2023 (FY ending 2023-12-31) | $6.97B | $321.1M | $5.54B |
| 2022 (FY ending 2022-12-31) | $7.51B | $686.5M | $6.29B |
| 2021 (FY ending 2021-12-31) | $7.39B | $572.6M | $7.02B |
| 2020 (FY ending 2020-12-31) | $6.39B | $116.6M | $4.89B |
| 2019 (FY ending 2019-12-31) | $6.04B | $37.8M | $5.12B |
| 2018 (FY ending 2018-12-31) | $5.86B | -$86.9M | $6.92B |
| 2017 (FY ending 2017-12-31) | $1.25B | -$112.7M | — |
Related
- ATO revenue, net income and debt history (Atmos Energy Corp)
- AUR revenue, net income and debt history (Aurora Innovation, Inc.)
- AVT revenue, net income and debt history (Avnet, Inc.)
- AVY revenue, net income and debt history (Avery Dennison Corporation)
- AWK revenue, net income and debt history (American Water Works Company, Inc.)
- AXON revenue, net income and debt history (Axon Enterprise, Inc.)
- AXP revenue, net income and debt history (American Express Co)
- AXSM revenue, net income and debt history (Axsome Therapeutics, Inc.)
Last updated Oct 16, 2026, 10:42 PM ET. Data only, not financial or tax advice.